spacer
home > pmps > autumn 2019 > five ways ar is revolutionising the manufacturing industry
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Five Ways AR is Revolutionising the Manufacturing Industry





“Simply put, we believe augmented reality is going to change the way we use technology forever” Tim Cook, Apple CEO at the fourth quarter earnings call, 2017

Prior to 2016, augmented reality (AR) in manufacturing was merely a pipe dream. Now, the potential for AR is recognised in many industries, including pharmaceutical manufacturing. The technology allows workers wearing transparent AR glasses to see both the real world around them as well as virtual information projected on their glasses to help them get their job done. All of this is hands free and at the location where the work is needed. AR is poised to revolutionise the manufacturing plant floor.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Patrick Liddy is a qualified Electrical Engineer BEng, CEM, MIEI from University College Dublin, Ireland, and holds a diploma in Business from Dublin Institute of Technology, Ireland. He brought innovation to the electricity market by founding Activation Energy, an energy efficiency software platform working with large energy users, and, following an acquisition by Nasdaq listed EnerNOC in 2014, led the company to be the largest demand response company both in Ireland and the UK. When Patrick first encountered AR smart glasses, he was convinced the technology would change how industry gets work done. In 2017, he re-entered the entrepreneurial space, founding UtilityAR, an AR software developer that creates AR solutions for utilities, industry, and other organisations who manage large portfolios of physical assets. The company now boasts local and multinational clients in the data centre, pharma, and utility sectors.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation

SAN DIEGO, Calif. & CAMBRIDGE, England, May 20, 2020 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, and Mundipharma today announced that the first patient has been dosed in its ReSPECT pivotal Phase 3 clinical trial evaluating the efficacy and safety of the company’s lead antifungal candidate, rezafungin, for the prevention of invasive fungal disease in patients undergoing allogeneic blood and marrow transplantation (BMT). Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of severe fungal infections.
More info >>

White Papers

Key to Outsourcing Method Development and Validation: A Pragmatic Approach

RSSL

In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation. As companies are focussing on achieving ever shorter times of drug to market, it is vital that a tailored, pragmatic approach is adopted when engaging in both method development and validation activities for an Active Pharmaceutical Ingredient (API) or drug product (DP). Although methods still require a high degree of robustness, the overall strategy should encompass a full evaluation of the regulatory requirements applicable to the particular phase of the drug life-cycle; this is pivotal in Key to Outsourcing Method Development and Validation A Pragmatic Approach order to ensure a successful regulatory submission, where the applicant must demonstrate suitable validation of all methods used to support the filing.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement